SmallCaps
ASX:ECSPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis cultivator and manufacturer located in Northwest Victoria.

$0.006 -$0.001 (-14.29%)AUD · Closed
-25.0%52-week return
Day Range
$0.006$0.006
52 Week Range
$0.003$0.010
Volume
1.62M
Avg Volume (10D)
812.46K
Market Cap
$9.61M
The company

The business

What ECS Botanics Holdings Ltd does

ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The Company utilizes progressive and cultivation methodologies to produce medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. The Company is a producer and supplier of affordable, premium-grade medicinal cannabis. The Company services both the Australian market and key international markets. It specializes in cultivating cannabis, which after drying and curing, is supplied as a trimmed flower for inhalation, or extracted into resin for further formulation or manufacturing.

Incorporated
AUS
Public since
1983-04-11
Employees
220
Advertisement

Small Caps Research

Independent ASX small-cap coverage

No research on ECS Botanics Holdings Ltd yet

We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise ECS based on demand.

Share price & key data

Share price

OHLC · volume · moving averages
$0.006+$0.001 (+20.00%)over 6M
Hi$0.007Lo$0.003
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
$0.006
Prev Close
$0.007
Day High
$0.006
Day Low
$0.006
52wk High
$0.010
52wk Low
$0.003

Valuation

Multiples
Market Cap
$9.61M
Shares Out
1.60B
Price/Book
0.40

Trading Activity

Volume & book
Volume
1.62M
Value Traded
$9.74K
Bid
$0.005 × 12,868,631
Ask
$0.006 × 5,886,970
Avg Vol 10D
812.46K

Performance

Total return
1 Day
+0.00%
5 Day
+0.00%
13 Week
+20.00%
52 Week
-25.00%
YTD
-7.69%
Peers & news

Latest news

From the Small Caps desk
ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter
Biotechnology

ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter

ECS Botanics Holdings (ASX: ECS) has delivered a positive net operating cash flow of $140,000 for the three months to end September, representing an improvement of $1.6 million on the June quarter and $900,000 on the same time last year. The company’s direct-to-consumer (B2C) strategy generated strong results to complement its established business-to-business (B2B) and export […]

ECS Botanics reports 50% increase in cannabis yields with new crop enclosure designs
Biotechnology

ECS Botanics reports 50% increase in cannabis yields with new crop enclosure designs

Australian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has reported a 50% increase in cannabis flower yields following the first harvest from its redesigned protective crop enclosures. The harvest produced 656 kilograms (wet weight) of flower compared to the previous high of 437kg of the same strain, also recording improvements in flower quality […]

ECS Botanics signs medicinal cannabis supply deal with MediCann Health
Biotechnology

ECS Botanics signs medicinal cannabis supply deal with MediCann Health

Victorian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has secured a deal to supply $24 million of pharmaceutical-grade medicinal cannabis dried flower to Perth-based MediCann Health. The agreement will commence in January 2024 with over four tonnes of product to be delivered exclusively to MediCann over five years. It stipulates annual volumes of […]

Ongoing cannabis product demand drives more revenue growth for ECS Botanics
Biotechnology

Ongoing cannabis product demand drives more revenue growth for ECS Botanics

Medicinal cannabis and hemp company ECS Botanics (ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent […]

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

Full broker research library
Complete CEO interview archive
IPO calendar and alerts
New research alerts
Mobile notifications
Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.